Advertisement

Topics

Triphase Accelerator Corporation Company Profile

11:10 EST 20th November 2018 | BioPortfolio

Triphase Accelerator is a private drug development company with a primary focus on oncology and with operations in Toronto and San Diego. Triphase Accelerator is dedicated to advancing novel compounds through Phase 2 proof-of-concept clinical studies using a unique, science-based, high-quality model that is faster and more cost-effective than traditional pharmaceutical and biotech industry drug development approaches. Triphase Accelerator was spun out of the Ontario Institute for Cancer Research (OICR), with support from the Fight Against Cancer Innovation Trust (FACIT), MaRS Innovation and MaRS. It has a strategic relationship with Celgene for oncology-focused drug development opportunities. For more information, visit www.triphaseco.com or Linkedin.


News Articles [227 Associated News Articles listed on BioPortfolio]

Triphase Accelerator Corp Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 13082018] Prices from USD $250

SummaryTriphase Accelerator Corp Triphase Accelerator is a biotechnology development company that acquires and develops novel therapeutics for the treatment of cancer. The company's pipeline products ...

Triphase Accelerator Corp Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 14062018] Prices from USD $250

SummaryTriphase Accelerator Corp Triphase Accelerator is a biotechnology development company that acquires and develops novel therapeutics for the treatment of cancer. The company's pipeline products ...

Scientists Present Ideas for Next-Gen Accelerator Experiments

NewsAn advisory committee is evaluating proposals for first experiments at SLAC's future FACET-II accelerator facility.

6 startups enter Boston Scientific-funded medtech accelerator

Six medtech startups have been accepted into startup accelerator gener8tor's second gBETA Medtech accelerator, a Boston Scien -More- 

Ky. accelerator partners with universities to create medtech hub

Louisville, Ky.-based health care-focused startup accelerator XLerateHealth is collaborating with the University of Kentucky, -More- 

Largest Startup Class Yet Enters UC Berkeley’s Expanding Accelerator

More than a hundred startup teams are beginning a training and mentoring program this month at the Berkeley SkyDeck Accelerator—the largest group ever accepted to the UC Berkeley program since i...

UK accelerator secures cell and gene therapy production licenses

Autolus, Cell Medica, Adaptimmune and Freeline are some of the companies already working with the accelerator.

Boomtown, COPIC Launch Patient Safety HealthTech Startup Accelerator

Boulder, CO-based startup accelerator Boomtown and COPIC, a medical liability insurance provider recognized for its innovative patient safety and risk management, have announced a multi-year agreement...

PubMed Articles [54 Associated PubMed Articles listed on BioPortfolio]

Electrochemical Property-Structure Correlation for Ni-based Layered Na-ion Cathodes.

A class of Ni-based layered NaxNi0.5Mn0.3Co0.2O2 oxide composites is prepared via a solid-state process. Mixed P-, O- and P-/O-type phases can be obtained by tuning the Na content and annealing temper...

A photon source model based on particle transport in a parameterized accelerator structure for Monte Carlo dose calculations.

An accurate source model of a medical linear accelerator is essential for Monte Carlo (MC) dose calculations. This study aims to propose an analytical photon source model based on particle transport i...

An ultrasensitive electrochemiluminescence biosensor for detection of MicroRNA by in-situ electrochemically generated copper nanoclusters as luminophore and TiO as coreaction accelerator.

Herein, we constructed an ultrasensitive electrochemiluminescence (ECL) biosensor for detecting microRNA-21 (miR-21) based on in-situ generation of copper nanoclusters (Cu NCs) as luminophore and tita...

Design considerations for a Pulse Line Ion Accelerator (PLIA)-based PET isotope generator.

Positron emission tomography (PET) imaging remains limited by the cost associated with on-site production of short half-life, positron emitting isotopes. In this work, we examine the use of a pulse li...

Dedicated linear accelerator radiosurgery for classical trigeminal neuralgia: a single-center experience with long term follow-up.

During the past decades, stereotactic radiosurgery (SRS) and Gamma Knife in particular have proven its safety and efficacy for drug-resistant classical trigeminal neuralgia (CTN). However, few large s...

Clinical Trials [19 Associated Clinical Trials listed on BioPortfolio]

First-In Man (FIM) Study MR-Linac

Investigational device is the Magnetic resonance imager linear accelerator. Five (5) patients with bone metastases will be treated with palliative intention in this study. The goal is to c...

Evaluation of Capsulotomy by Linear Accelerator Radiosurgery in Severe and Refractory Obsessive-compulsive Disorder

The aim of this study is to evaluate, through a pilot study with about ten cases, if bilateral ventral capsulotomy by linear accelerator enable modification of obsessive-compulsive symptom...

Stereotactic Body Radio Therapy (SBRT) for Early-Stage Non Small Cell Lung Cancer (NSCLC)

The purpose of this study is to evaluate local disease control after 2 years in patients with non-metastatic, non-operated non-small-cell lung cancer treated by radiotherapy. Eligible pat...

Autoimmune Diabetes Accelerator Prevention Trial

The autoimmune diabetes ACCELERATOR PREVENTION TRIAL (adAPT) is based on the accelerator hypothesis. The trial is designed to establish whether metformin, an oral hypoglycaemic agent that ...

Molecular-Guided Surgery for Pancreatic and GI Neuroendocrine Cancers

The purpose of this study is to see if we can use 68Gallium- positron emission tomography and computer tomography (PET/CT) scans using NETSPOT® (Advanced Accelerator Applications USA, Inc...

Companies [240 Associated Companies listed on BioPortfolio]

Triphase Accelerator Corporation

Triphase Accelerator is a private drug development company with a primary focus on oncology and with operations in Toronto and San Diego. Triphase Accelerator is dedicated to adva...

Triphase

Triphase is a private, oncology- focused accelerator dedicated to advancing compelling, well differentiated drugs through human proof of concept (Phase II) faster and more efficie...

Accelerator Life Science Partners

Accelerator Life Science Partners catalyzes the development and commercialization of breakthrough biotechnology innovations. Accelerator is a trusted partner that provides the com...

Cydan

Cydan is an orphan drug accelerator that identifies and de-risks assets with therapeutic and commercial potential. The accelerator’s model evaluates programs for treating rar...

SKTA Innopartners

SKTA Innovation Accelerator is a different kind of accelerator based in Silicon Valley. We seed core technology startups by matching entrepreneurs with Strategic Partners committe...

More Information about "Triphase Accelerator Corporation" on BioPortfolio

We have published hundreds of Triphase Accelerator Corporation news stories on BioPortfolio along with dozens of Triphase Accelerator Corporation Clinical Trials and PubMed Articles about Triphase Accelerator Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Triphase Accelerator Corporation Companies in our database. You can also find out about relevant Triphase Accelerator Corporation Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record